The Impact of Income Inequality and National Wealth on Child and Adolescent Mortality in Low and Middle-income Countries
Overview
Authors
Affiliations
Background: Income inequality and national wealth are strong determinants for health, but few studies have systematically investigated their influence on mortality across the early life-course, particularly outside the high-income world.
Methods: We performed cross-sectional regression analyses of the relationship between income inequality (national Gini coefficient) and national wealth (Gross Domestic Product (GDP) averaged over previous decade), and all-cause and grouped cause national mortality rate amongst infants, 1-4, 5-9, 10-14, 15-19 and 20-24 year olds in low and middle-income countries (LMIC) in 2012. Gini models were adjusted for GDP.
Results: Data were available for 103 (79%) countries. Gini was positively associated with increased all-cause and communicable disease mortality in both sexes across all age groups, after adjusting for national wealth. Gini was only positively associated with increased injury mortality amongst infants and 20-24 year olds, and increased non-communicable disease mortality amongst 20-24 year old females. The strength of these associations tended to increase during adolescence. Increasing GDP was negatively associated with all-cause, communicable and non-communicable disease mortality in males and females across all age groups. GDP was also associated with decreased injury mortality in all age groups except 15-19 year old females, and 15-24 year old males. GDP became a weaker predictor of mortality during adolescence.
Conclusion: Policies to reduce income inequality, rather than prioritising economic growth at all costs, may be needed to improve adolescent mortality in low and middle-income countries, a key development priority.
Setiawan E, Cassidy-Seyoum S, Thriemer K, Carvalho N, Devine A Pharmacoeconomics. 2024; 42(8):865-877.
PMID: 38874846 PMC: 11249595. DOI: 10.1007/s40273-024-01402-x.
The cost of inaction on health equity and its social determinants.
Yerramilli P, Chopra M, Rasanathan K BMJ Glob Health. 2024; 9(Suppl 1).
PMID: 38589049 PMC: 11015166. DOI: 10.1136/bmjgh-2023-012690.
Li X, Bachwenkizi J, Chen R, Kan H, Meng X BMC Public Health. 2023; 23(1):2366.
PMID: 38031047 PMC: 10685554. DOI: 10.1186/s12889-023-17284-1.
Simoes Gaspar R, Rossi L, Hone T, Dornelles A Lancet Reg Health Am. 2023; 2:100042.
PMID: 36779037 PMC: 9904117. DOI: 10.1016/j.lana.2021.100042.
Gebremichael B, Hailu A, Letebo M, Berhanesilassie E, Shumetie A, Biadgilign S Health Res Policy Syst. 2022; 20(1):130.
PMID: 36437476 PMC: 9702649. DOI: 10.1186/s12961-022-00932-0.